Excited to announce that the first issue of #ASMCaseReports is HERE! 🎉 Congratulations to all of our authors! 🙌 @asm.org @burnhambugdoc.bsky.social @nicholasmoore.bsky.social
Read the fully open-access issue: journals.asm.org/toc/asmcr/cu...
Read the fully open-access issue: journals.asm.org/toc/asmcr/cu...
January 7, 2025 at 8:58 PM
Excited to announce that the first issue of #ASMCaseReports is HERE! 🎉 Congratulations to all of our authors! 🙌 @asm.org @burnhambugdoc.bsky.social @nicholasmoore.bsky.social
Read the fully open-access issue: journals.asm.org/toc/asmcr/cu...
Read the fully open-access issue: journals.asm.org/toc/asmcr/cu...
Resolution of acute rejection in a bilateral double-lung transplanted cystic fibrosis patient following phage intervention.
DOI: 10.1128/asmcr.00058-24
https://pubmed.ncbi.nlm.nih.gov/41244966/
DOI: 10.1128/asmcr.00058-24
https://pubmed.ncbi.nlm.nih.gov/41244966/
Resolution of acute rejection in a bilateral double-lung transplanted cystic fibrosis patient following phage intervention - PubMed
This case underscores the potential of phage therapy to complement traditional treatments in managing chronic bacterial infections in CF patients, though further studies are needed to optimize treatment protocols and understand the role of phages in modulating the bacterial population.
pubmed.ncbi.nlm.nih.gov
November 24, 2025 at 11:53 PM
Resolution of acute rejection in a bilateral double-lung transplanted cystic fibrosis patient following phage intervention.
DOI: 10.1128/asmcr.00058-24
https://pubmed.ncbi.nlm.nih.gov/41244966/
DOI: 10.1128/asmcr.00058-24
https://pubmed.ncbi.nlm.nih.gov/41244966/
The September issue of #ASMCaseReports is here! 🎇 Congrats to author Malgorzata K. Kopczyk and team for making the cover! Conventional tests (the "radar") can miss heteroresistance - a subpopulation of cells resistant to the antibiotic. @asm.org
Read the issue: journals.asm.org/toc/asmcr/1/5
Read the issue: journals.asm.org/toc/asmcr/1/5
September 3, 2025 at 1:00 PM
The September issue of #ASMCaseReports is here! 🎇 Congrats to author Malgorzata K. Kopczyk and team for making the cover! Conventional tests (the "radar") can miss heteroresistance - a subpopulation of cells resistant to the antibiotic. @asm.org
Read the issue: journals.asm.org/toc/asmcr/1/5
Read the issue: journals.asm.org/toc/asmcr/1/5
The newest issue of #ASMCaseReports is HERE! 🧠 Congrats to Yerramilli & colleagues for making the cover for our May 2025 issue. Their case discusses anti-NMDA receptor encephalitis following infection with Murray Valley encephalitis virus. @asm.org
Free to read:
journals.asm.org/toc/asmcr/1/3
Free to read:
journals.asm.org/toc/asmcr/1/3
May 6, 2025 at 5:28 PM
The newest issue of #ASMCaseReports is HERE! 🧠 Congrats to Yerramilli & colleagues for making the cover for our May 2025 issue. Their case discusses anti-NMDA receptor encephalitis following infection with Murray Valley encephalitis virus. @asm.org
Free to read:
journals.asm.org/toc/asmcr/1/3
Free to read:
journals.asm.org/toc/asmcr/1/3
Today's DG GROW @ec.europa.eu #competitiveness assessment confirms our #EES2025 findings. The #ASMCR highlights barriers to innovation & growth. Urgent action is needed to cut red tape, attract investment & unlock the #SingleMarket.
Read our #EES2025: bit.ly/EES2025_Report
Read our #EES2025: bit.ly/EES2025_Report
Eurochambres Economic Survey 2025 - Eurochambres
The Eurochambres Economic Survey 2025 is a unique piece of qualitative research carried out with the cooperation of 27 national chambers of commerce and industry across the continent. Over the years, ...
bit.ly
January 29, 2025 at 2:10 PM
Today's DG GROW @ec.europa.eu #competitiveness assessment confirms our #EES2025 findings. The #ASMCR highlights barriers to innovation & growth. Urgent action is needed to cut red tape, attract investment & unlock the #SingleMarket.
Read our #EES2025: bit.ly/EES2025_Report
Read our #EES2025: bit.ly/EES2025_Report
Successful treatment of macrolide-resistant Mycobacterium abscessus infection using multi-drug regimens including dual β-lactams and phage therapy: case reports in two children.
DOI: 10.1128/asmcr.00087-24
https://pubmed.ncbi.nlm.nih.gov/41244981/
DOI: 10.1128/asmcr.00087-24
https://pubmed.ncbi.nlm.nih.gov/41244981/
Successful treatment of macrolide-resistant Mycobacterium abscessus infection using multi-drug regimens including dual β-lactams and phage therapy: case reports in two children - PubMed
Successful treatment of macrolide-resistant <i>M. abscessus</i> infections in children can be achieved using multi-drug regimens including novel dual β-lactam combinations and phage therapy. Dose adjustment with therapeutic drug monitoring can ameliorate some drug-induced toxicities in children.
pubmed.ncbi.nlm.nih.gov
November 20, 2025 at 7:46 AM
Successful treatment of macrolide-resistant Mycobacterium abscessus infection using multi-drug regimens including dual β-lactams and phage therapy: case reports in two children.
DOI: 10.1128/asmcr.00087-24
https://pubmed.ncbi.nlm.nih.gov/41244981/
DOI: 10.1128/asmcr.00087-24
https://pubmed.ncbi.nlm.nih.gov/41244981/
The July issue of ASM Case Reports is here! Congrats to Orbea & colleagues for making the cover, featuring a striking image of Exserohilum cells - the cause of invasive fungal sinusitis in this case. #ASMCaseReports @asm.org @burnhambugdoc.bsky.social
journals.asm.org/toc/asmcr/1/4
journals.asm.org/toc/asmcr/1/4
July 1, 2025 at 6:11 PM
The July issue of ASM Case Reports is here! Congrats to Orbea & colleagues for making the cover, featuring a striking image of Exserohilum cells - the cause of invasive fungal sinusitis in this case. #ASMCaseReports @asm.org @burnhambugdoc.bsky.social
journals.asm.org/toc/asmcr/1/4
journals.asm.org/toc/asmcr/1/4
Resolution of acute rejection in a bilateral double-lung transplanted cystic fibrosis patient following phage intervention.
DOI: 10.1128/asmcr.00058-24
https://pubmed.ncbi.nlm.nih.gov/41244966/
DOI: 10.1128/asmcr.00058-24
https://pubmed.ncbi.nlm.nih.gov/41244966/
Resolution of acute rejection in a bilateral double-lung transplanted cystic fibrosis patient following phage intervention - PubMed
This case underscores the potential of phage therapy to complement traditional treatments in managing chronic bacterial infections in CF patients, though further studies are needed to optimize treatment protocols and understand the role of phages in modulating the bacterial population.
pubmed.ncbi.nlm.nih.gov
November 22, 2025 at 7:49 PM
Resolution of acute rejection in a bilateral double-lung transplanted cystic fibrosis patient following phage intervention.
DOI: 10.1128/asmcr.00058-24
https://pubmed.ncbi.nlm.nih.gov/41244966/
DOI: 10.1128/asmcr.00058-24
https://pubmed.ncbi.nlm.nih.gov/41244966/
🧫 Got a group of related clinical cases? Now you can turn them into a Case Series, a new article type from #ASMCaseReports!
📚 Learn about Case Series: asm.social/2CM
🔗 Submit your Case Series article: asm.social/2CL
#ASMJournals #CaseSeries
📚 Learn about Case Series: asm.social/2CM
🔗 Submit your Case Series article: asm.social/2CL
#ASMJournals #CaseSeries
September 30, 2025 at 7:30 PM
🧫 Got a group of related clinical cases? Now you can turn them into a Case Series, a new article type from #ASMCaseReports!
📚 Learn about Case Series: asm.social/2CM
🔗 Submit your Case Series article: asm.social/2CL
#ASMJournals #CaseSeries
📚 Learn about Case Series: asm.social/2CM
🔗 Submit your Case Series article: asm.social/2CL
#ASMJournals #CaseSeries
Dear #IDSky,
Do you have a really cool case that you'd like to publish? One that involved a unique or challenging diagnostic approach? If so, I would encourage you to submit your case to the BRAND NEW ASM Case Reports journal.
Read more here: doi.org/10.1128/asmc...
journals.asm.org/journal/asmcr
Do you have a really cool case that you'd like to publish? One that involved a unique or challenging diagnostic approach? If so, I would encourage you to submit your case to the BRAND NEW ASM Case Reports journal.
Read more here: doi.org/10.1128/asmc...
journals.asm.org/journal/asmcr
November 12, 2024 at 1:04 PM
Dear #IDSky,
Do you have a really cool case that you'd like to publish? One that involved a unique or challenging diagnostic approach? If so, I would encourage you to submit your case to the BRAND NEW ASM Case Reports journal.
Read more here: doi.org/10.1128/asmc...
journals.asm.org/journal/asmcr
Do you have a really cool case that you'd like to publish? One that involved a unique or challenging diagnostic approach? If so, I would encourage you to submit your case to the BRAND NEW ASM Case Reports journal.
Read more here: doi.org/10.1128/asmc...
journals.asm.org/journal/asmcr